FINWIRES · TerminalLIVE
FINWIRES

Titan Mining在美國盤前交易中上漲4.7%,稱其在Kilbourne的擴張具有「巨大潛力」。

-- 泰坦礦業(Titan Mining,股票代碼:TI.TO)週四美股盤前交易中上漲4.7%,此前該公司公佈鑽探結果,證實基爾伯恩(Kilbourne)礦區現有資源邊界以東2500英尺範圍內存在石墨礦化,凸顯了該礦床在2025年初步經濟評估礦山計劃之外具有「顯著的擴展計劃潛力」。 該公司還更新了其鍺相關業務活動,並詳細介紹了2026年石墨和鋅的勘探計劃。 泰坦表示,基爾伯恩東部鑽探證實,層控石墨礦化在概念性礦坑設計以東2500英尺範圍內持續存在,“支持向東顯著擴展潛在礦產資源估算”,並有望將礦山壽命延長至2025年初步經濟評估中設定的13年基準期之外。 此勘探結果的亮點包括:在 57.9 英尺至 313.0 英尺深度範圍內,石墨碳含量為 3.0% 的礦段厚度為 255.1 英尺,其中包括在 200.0 英尺至 297.0 英尺深度範圍內,石墨碳含量為 3.5% 的 97.0 英尺礦段厚度。這是迄今為止在東部延伸區記錄到的最寬礦段。 「這些結果進一步鞏固了我們先前的判斷,即 Kilbourne 石墨礦系統比目前礦產資源估算範圍所反映的規模更大、更具可擴展性,」Titan 公司總裁兼執行長 Rita Adiani 表示。 “我們看到礦化帶在現有邊界之外持續存在,且品位與主礦床一致,這支持了資源擴張、延長礦山壽命和提高開發靈活性的潛力。同時,我們 2026 年的勘探戰略旨在通過嚴謹的勘探方法,釋放石墨和鋅的更多價值。” 泰坦公司表示,在帝國州礦業公司現有製程中發現的鍺主要與雲母和其他脈石材料共生,而非硫化物。 該公司補充說:“這是一項重要的發現,它明確了回收策略,並為現有鋅礦業務帶來額外的現金流機會。” 該公司2026年的勘探計畫將推進其12萬英畝土地上的石墨、鋅和關鍵礦產目標的勘探。區域鋅礦目標包括本德(Bend)、莫斯里奇(Moss Ridge)和博斯威克(Bostwick)。 計劃在這些目標區域進行約2萬英尺的鑽探。在本德,工作重點將是地球化學分析和後續鑽探。計畫在莫斯里奇進行約2000英尺的鑽探,在博斯威克進行約1500英尺的鑽探。 Titan股票昨天在加拿大下跌0.14美元,跌幅3.5%,至3.92美元;在美國下跌4%。

Related Articles

Asia

Update: Origin Energy Reports Lower March Quarter Production; Shares Fall 3%

(Updates to add stock movement in the headline and last paragraph)Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.The company's shares fell 3% in recent Monday trade.

$ASX:ORG
Asia

Alterity Therapeutics Secures US FDA Support for ATH434 Phase Three Program

Alterity Therapeutics (ASX:ATH) said it received positive feedback from a second type C meeting with the US Food and Drug Administration (FDA) on its planned phase three program for drug candidate ATH434, aimed at treating multiple system atrophy (MSA), according to a Monday filing with the Australian bourse.MSA is a progressive neurodegenerative disorder affecting autonomic and motor function with no approved disease-modifying therapies.The US FDA provided supportive written feedback on the program's chemistry, manufacturing, and controls, complementing earlier guidance from a separate type C meeting on clinical pharmacology and non-clinical development, the filing added.

$ASX:ATH
Asia

Xinyuan Property Management's CFO Resigns

Xinyuan Property Management Service's (HKG:1895) chief financial officer, Wang Yong, has resigned, effective April 26, according to a Monday Hong Kong bourse filing.Wang stepped down to devote more time to personal commitments, the company said.The company said the resignation will not affect its normal operations, with Wang's duties to be reallocated internally on an interim basis.Xinyuan Property Management added that it is seeking a suitable replacement for the chief financial officer role.

$HKG:1895